Speakers and panelists
Day I - Emerging Growth Sesson
Day I - Nordic SME Program, Lion's Den
Day II: Markets Session
Day I: Emerging Growth Session
Andreas Dirnagl
Senior Advisor, Healthcare DNB Bank
Anne Grabe
Global Head of Healthcare, DNB Bank
Alison Schecter
CMO, Head of R&D, Axcella, Sarepta, Sanofi
Anders Månsson
CEO, Oncoinvent
Blake Marggraff
CEO, Lightbeam Health Solutions
Carsten Borring
Head of Listings and Capital Markets, Nasdaq Copenhagen
Christopher Leo
Managing Director Healthcare Strategy, Back Bay Life Science Advisors
Dan Schneider
CEO, PhotoCure
Gareth Hicks
Vice President & Head Gastrointestinal, Drug Discovery Takeda
Gaye Bok
Partner, AI and Digital Innovation Fund Mass General Brigham
Gregory Benning
Managing Director and Head of Investment Banking, Back Bay Life Science Advisors
Homer Pien
Former Chief Scientific Officer, Philips
James Cirenza
Managing Director, DNB Markets
Jonathan Gertler
Chief Executive Officer, Back Bay Life Science Advisors
Maha Malik
Investment Banking Associate Director, DNB Markets
Marcela Del Carmen
Professor of Obstetrics, Gynecology & Reproductive Biology, Harvard Medical School; Massachusetts General Physicians Organization, President; Executive Vice President, Mass General Brigham
Martin Jönsson
CEO, AlzeCure Pharma
Ole Vorm
CEO, Evosep
Oskar Bosson
VP, Head of IR & Communication, BioArctic
Patrick Moriarty
Executive Director, Business Development Merck
Peter Bak
Managing Director Healthcare Strategy, Back Bay Life Science Advisors
Sebastian Intveen
Director, Healthcare Investment Banking, DNB Markets
Sebastian Søderberg
CEO, Bactolife
Steve Gauldie
Managing Director Healthcare Strategy, Back Bay Life Science Advisors
Thomas Holm Pedersen
CEO, NMD Pharma
Thomas N. Kledal
CEO, Synklino
Thomas Tangen
Head of Healthcare USA, DNB Corporate Banking
Torben Sandgren,
CEO, UNEEG
Vasilios Kofitsas
Managing Director Investment Banking, Back Bay Life Science Advisors
Ilir Mujalovic
Partner, Shearman & Sterling
Day I - Nordic SME Program, Lion's Den
Nalinava Sen Gupta
CEO and Boardmember of iNANOD
Thomas Due
Boardmember of iNANOD
Patrik Strömberg
CEO, AnaCardio
Åge Nærdal
CEO and Co-founder of InsuLife
Knut Løkke
CEO and Founder of MyWorkout
Michael Rützler
CEO and co-founder of Apoglyx
Gaute Naespe
CEO, Emergence AS | Inform Life™
Dr. Verena Schöwel-Wolf
CEO and co-founder of MyoPax
Jeppe. C. Mouritsen
MSc, DSc and founder of Henlez
Day II: Markets Session
On day two we present the best publicly-traded Nordic biopharma and medical technology companies focused in areas with high patient needs, including cancer, GI, metabolism, neurology, rare diseases, transplantation, vaccines, and others. In addition, come hear from our expert panel on the current state of the Global Healthcare Capital Markets and where we are headed.
See list of speakers and panelists below.
External speakers and panelists
David Heiberg Landsted
Investor Relations Manager, Novo Nordisk
Daniel Rankin
Head of Strategy and Corporate Development, SOBI
Joel Morales
EVP & Chief Financial Officer, Alvotech
Kristoffer Nordstrom
CFO, XVIVO
Renee Aguiar-Lucander
CEO, Calliditas Therapeutics
Frederik Johansson
CFO, Calliditas Therapeutics
Oskar Bosson
VP Communications and Investor Relations, BioArctic
Per Plotnikof
VP Corporate Communications, Investor Relations and Strategic Planning, ALK-Bello
Carlos de Sousa
CEO, Ultimovacs
Palle Holm Oleson
Chief Specialist Investor Relations, Lundbeck
Ralf Sass Sorensen
VP Investor Relations and Communications, Bavarian Nordic
Day II - Internal speakers and panelists
Jonatan Andersson
Equity Research Analyst, DNB Markets Stockholm
Patrik Ling
Senior Equity Research Analyst, DNB Markets Stockholm
Rune Majlund Dahl
Senior Equity Research Analyst, DNB Markets Oslo
Sebastian Intveen
Director - Healthcare Investment Banking, DNB Markets Oslo